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EFFECTS OF PATIENT FACTORS ON IMPLANTATION RATES IN
IN VITRO FERTILIZATION
Heidi Richardson
Sofia Soto

Abstract
The purpose of this report is to evaluate the effects of patient factors and embryo quality
on the implantation rate in In Vitro Fertilization (IVF). For this report, statistical methods are
used to test the significance of several patient and embryo characteristics on embryo
implantation rate. This project is an analysis of data collected from over 36,000 patients.
The analysis concluded several findings. There was enough statistical evidence to
conclude that age was significant in regards to implantation rate and FSH levels. As the patient
ages, the amount of FSH levels found in their blood increases. A patient with high FSH levels
produces less oocytes than a patient with a lower FSH level. A low number of oocytes produced
will in return yield a lower implantation rate. When body-mass index and smoking preference
were analyzed, the analysis showed that the null hypothesis could not be rejected. When looking
at embryo morphology, they played a significant role within percentile groups. The most
significance was shown within the embryos that were transferred in day 5. These conclusions
support the fact that since embryos are graded as good quality depending on their morphology,
any improvements can be seen through the improvement of this selection process.
There are several direct and indirect costs that result from IVF treatments. These treatments are
very costly ranging from $16,000 - $800,000, and can represent a significant economic burden for
families. Besides having a monetary impact, IVF procedures also have a great psychological impact on
patients. Undergoing an IVF treatment can greatly affect a patient's emotional, physical, and relational
status.
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Introduction
By using various statistical methods, the purpose of this report is to expose and
understand the patient factors that affect In Vitro Fertilization (IVF) performance that may
potentially contribute to an increased success rate and reduce variation in the process. The
human body and this process are so complex that it is impossible to ignore the effects that a
patient has on the type of embryo that is produced, or how the clinics method of growing
embryos can affect the type of embryo that is produced. This report is going to focus on the
patient factor aspect and will have a design analysis around blocking the effect of the clinics and
embryo types. The principle patient factors that will be covered in this report are whether the
patient was a smoker or not, their age, Follicle Stimulating Hormone (FSH) levels, and their
Body-Mass Index (BMI) score. A detailed study of the following objectives will be analyzed in
this report:
● Investigate the effect of patient’s age on Implantation Rate
● Investigate the effect of patient’s smoking preference on Implantation Rate
● Investigate the effect of patient BMI on implantation Rate
● Investigate the effect of patient FSH level on implantation Rate
● Analysis of age effecting FSH level in patient’s blood
● Analysis of FSH levels effecting number of oocytes produced
● Analysis of implantation rate by percentile clinics on embryo types
● Analysis of implantation rate effect on number of oocytes retrieved
A master’s thesis is currently being conducted encompassing the two factors this report
will not cover (Clinic Percentile and Embryo Morphology). Based on the results of this study,
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the statistically significant patient factors will help create a better process to improve success
rates in the lower percentile clinics.
The proposal for this experiment stemmed from Dr. Alex J. Steinleitner's clinic located in
San Luis Obispo, which specializes in In-Vitro Fertilization. Currently, some clinics around the
US, including his, have a success rate of over 70 percent while others are closer to 30 percent.
Dr. Steinleitner wants to find assignable causes for variation between clinics and implement
process controls to increase the success rate of the underperforming clinics. In order to achieve
any conclusions, a wide range of data is necessary to begin the analysis phase. IVF clinics
throughout the United States have accumulated data for 3 years, in order to make this experiment
possible. The data includes but is not limited to the woman’s age, embryo score, donor egg/non
donor egg.
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Literature Review
History of IVF

The search for a cure to infertility has long been researched since 1855 when Dr. J.
Marion Sims believed that infertility could be cured through gynecological surgery or artificial
insemination. Nearly 30 years later the first child was born through artificial insemination by
physician William Pancoast. After this achievement, success in the field of assisted reproductive
technology progressed slowly. It wasn’t until 1968 that British scientist Robert Edwards teamed
with Patrick Steptoe and fertilized the first human eggs in vitro. Over the next nine years, the
public analyzed the ethics behind this discovery. In December of 1977 the British team
successfully grew an egg fertilized in vitro in a human uterus and on July 25 of 1978 their work
was official with the delivery of baby Louise Joy Brown. Since then, in vitro fertilization has
become a part of medical vernacular and over 450 IVF clinics have opened across the United
States (pbs.org).

The IVF Process

Normally, in order to conceive a baby, an egg and sperm are fertilized inside a woman’s
body. If the fertilized egg attaches to the lining of the womb and continues to grow, a baby is
born about 9 months later. This process is called natural or unassisted conception (Storcke).
Unfortunately, about 10% of women ages 15-44 in the United States have difficulty getting
pregnant or staying pregnant (Infertility). For this precise reason, Sir Robert Edwards was the
first pioneer of in-vitro fertilization (IVF) in 1978 (Johnson). IVF is a form of reproductive
assisted technology that helps a woman become pregnant and is usually chosen when other lessexpensive fertility techniques have proven to be unsuccessful because IVF itself is so expensive.
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There are five basic steps to IVF. The first one is the stimulation step, also known as
superovulation. In this step, the patient is given drugs to stimulate her ovaries and develop
multiple eggs, since most women usually produce only one egg per month. Step two is called
Egg Retrieval. Once the eggs are mature, a minor surgery called follicular aspiration is
performed to remove the eggs from the ovaries. During this procedure, a needle is placed
through the vaginal opening and into the ovaries containing the eggs. The needle is then
connected to a suction device that pulls the eggs out of each follicle, one at a time. The eggs then
get transferred to an embryology lab where they are evaluated for maturity. More on how to
evaluate the eggs will be discussed further in the literature review. Step three which is called
fertilization in the Lab is what comes next. At this stage, a fresh sample of sperm is collected in
which the best sperm is chosen for insemination. The sperm is placed together with the best
quality eggs and stored in a controlled chamber. If the doctor believes the chance of fertilization
is low, the sperm is then injected directly into the egg using a process called intra-cytoplasmic
sperm injection (ICSI). If the fertilization is successful, the oocytes and embryos will stay in the
lab for about 2-5 days (Keefe).
The next two steps are very important because they dictate which embryo will be the
most qualified to be transferred. Step four is called embryo culture/quality. During this step, the
laboratory staff will regularly check the embryo to ensure that it is growing properly. Once a
good embryo is identified, they are transferred during day 3 or day 5. Day 3 embryos are called
cleavage stage embryos and have about 4-8 cells. Day 5 embryos are called blastocyst embryos
and look like a ball of cells with liquid inside. The last step is called Embryo Transfer. This is the
stage in which the embryos are placed inside the woman’s uterus through her vagina. It is a
simple procedure that does not require anesthesia. During the process, the embryos are loaded
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into a thin tube called a catheter, and then inserted into the woman’s vagina. Pregnancy results if
an embryo sticks inside the lining of the womb and grows (Keefe).
It is possible to insert more than one embryo into the womb to have twins, triplets, or more. This
however is a complex issue that depends on several factors including a woman’s age. The
embryos that are not used may be frozen and implanted or donated on a later date (Storcke).

Cleavage Stage (Day 3) vs. Blastocyst Stage (Day 5) Embryos

Embryos from assisted reproductive technologies in vitro fertilization (IVF), are usually
transferred into the woman’s uterus at either the early cleavage stage (Day 2 to 3 after egg
collection) or blastocyst stage (Day 5 to 6 after egg collection). Currently, doctors’ majority
opinion is that transferring embryos at the blastocyst stage is the most biologically correct stage
for embryos to be in the uterus since earlier stages are naturally in the fallopian tube (Wang).
They also benefit from the embryo staying in the laboratory longer, since it may give doctors
more time to select the best quality embryo(s). The objective of this experiment was to evaluate
whether the live birth rate and other pregnancy outcomes can be improved by Day 5 to 6 transfer
compared with Day 2 to 3 embryo transfer (Wang).
The experiment consisted of seven trials (n=1446 cases). The results confirmed that
blastocyst transfer was statistically significantly associated with an increase in clinical pregnancy
rate with an odds ratio (OR) of 1.43% and confidence interval (CI), 1.15-1.78], implantation rate
(OR 1.38; 95% CI, 1.09-1.74) and ongoing pregnancy rate (OR 2.15; 95% CI, 1.57-2.94), and
also a reduction in the probability of first trimester miscarriage rate (OR 0.51; 95% CI, 0.300.87). The improvement in the live birth rate was also observed to have (OR 1.77; 95% CI, 1.322.37) (Wang).
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The above experiment results suggest that indeed, live birth rate and other pregnancy
outcomes are significantly improved if the embryo is transferred during the blastocyst stage
compared to the cleavage stage.

Quality: Defined

Currently, most labs use embryo morphology as the main quality indicator. It is a
noninvasive embryo selection technique that has been utilized since the early days of IVF. Of
course, this method has its limitations and room for error. Morphological assessments are not
always performed at constant time intervals, thus making variations in the score. For example, an
embryo scored early on day 2 can appear significantly different than the same embryo late on
day 2. The cell could morph from a 2-cell to a 4-cell during that time period, making this method
fairly crude and subjective (Montag, Toth, Strowitzki).
The main points that are analyzed in this widely used method include: fragmentation
percentage, the number of cells, shape of the cells at all days, and the appearance of the zona
pellucida, inner cell mass and trophectoderm of the blastocyst at day 5 (SART). Another study,
performed in 1999, found the characteristics that led to the highest pregnancy success. The
“characteristics of these top quality embryos were absence of multinucleated blastomeres, four or
five blastomeres on day 2, seven or more cells on day 3, and ≤20% anucleated fragments” (van
Royen).
Presently, it is known that the quality of the embryo can only be as good as the woman
carrying it. There are many factors that influence the success of IVF. Still, isolating the quality of
the embryo is a significant factor used to predict the success of the procedure.
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S.A.R.T. Embryo Scoring System

There have been numerous grading systems created to rank embryos in the processes
utilized in Assisted Reproductive Technology (ART) labs. Some systems use the overall
appearance of the cleavage stage embryo, others at the blastocyst stage, and some are more
complex that involve formulas to predict the possibility of pregnancy. Embryo quality has been
correlated with pregnancy success, and without having data of each emb
embryo
ryo score, high
variability in success rates occurred. Because of this diverse grading system and lack of a
convention, comparisons between clinics and overall quality control could not be performed. In
2004, “embryo morphology fields” were included in the Society of Assisted Reproductive
Technologies (SART) database (Racowsky). After this incorporation, SART developed their
own grading/scoring system which was made mandatory to include by March 2010. This system
had 3 goals: to be “1) simple, 2) comprised of fields that have a basis in scientific inquiry with
some proven predictive value, and 3) easily adopted in laboratories not routinely capturing these
parameters” (Racowsky). The following three
three-point
point system (Table 1) was developed:

Table 1:: SART Grading System ((Source: Racowsky)
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Since SART has mandated that embryo score be included in all datasets, much more accurate
predictions have been made in predicting pregnancy.
A study was conducted to evaluate the correlation between the SART scoring method and
ART single blastocyst embryo transfers. In the study, each blastocyst was given a grade based on
the SART scoring system and then statistical methods such as multiple logistic regression and
chi square analysis were used to correlate the scoring system to live birth rate. The study used a
sample of 717 single blastocyst transfer cycles that were fresh and autologous (Heitmann).
“The live birth rate was 52 % and included both elective and non-elective [single blastocyst
cycles] SBT. Chi square analysis showed higher live birth in good grade embryos as compared to
fair (p = 0.03) and poor (p = 0.02). Univariate binary logistic regression analysis demonstrated
SART embryo grading to be significantly correlated with both implantation and live birth (p <
0.01). This significance persisted when patient age, BMI, and the stage of the blastocyst were
controlled for with multiple logistic regression. In five patients with a poor blastocyst score,
there were no live births” (Heitmann).
From this study it can be seen that the SART grading method is a strong indicator in live
birth success and should be used when analyzing any ART data.
To test if SART’s grading method accounted for all factors influencing success in an
embryos morphology, Sophia Kamran, ET. Al. devised a study to see whether or not the
symmetry of the day 3 embryo was a significant predictor to pregnancy in addition to the 3 main
areas that the SART method uses: cell number, fragmentation and blastomere symmetry. In the
study, Kamran used MATLAB to measure the “roundness” of a day 3 embryo. Using statistical
methods, she found that this characteristic was not useful as an additional marker for embryo
selection. This finding helped to show the appropriateness of the SART grading system in
correlation with pregnancy success.
The NYU Langone Medical Center states that there is no standard classification system
for all fertility centers. Although most centers use the Gardner grading system for blastocysts,

11

each center created their own system for grading day-2 and 3 embryos as the technology
developed and, at this point, it would be too difficult for all centers to try and use a standard
grading method (NYU Langone Medical Center). For this reason, all data that is used in this
research is collected in the same database using the same methodology. Only clinics using the
SART grading method have contributed data.
Factors Influencing IVF Success:

Several external factors have been identified in reducing the success of IVF pregnancies;
ethnicity, smoking, age, patient Body Mass Index (BMI), and paternal BMI.
Ethnicity

Since IVF is a fairly new concept, there are many factors that could be contributing to
unsuccessful pregnancies. Most scientists have researched and experimented with the age of the
patients to see if this plays a major role in whether the process is successful. It is important
however, to take into account all of the possible variables that can influence the outcome of IVF
such as ethnicity. Can ethnicity be an influence on IVF? This is the question that a team of
researchers at Nottingham University in the UK set out to answer.
Ethnic minorities form a significant portion of couples undergoing (IVF) throughout the
world. It is important to let these patients know what their probabilities of success may be based
on their genetic makeup and variables that might affect their outcome. There have already been a
number of reports published on the relationship between ethnicity and IVF success. Asian
infertile women in the United States were reported to have a lower IVF success rate compared
with white woman (Jayaprakasan).
In other studies in the US, authors have reported that white woman also have more
biochemical pregnancies and live births compared to women from ethnic minorities. Including
12

but not limited to Hispanic and Asian. In the UK, studies that were published in the late 1990’s
reported that in the USA, South Asian Indian women had lower live birth rates when compared
to white woman despite their younger age and lower basal follicle stimulating hormone (FSH)
(Jayaprakasan).A follicle stimulating hormone is an acidic glycoprotein found in women that
stimulates the development of ovarian follicles (eggs) and stimulates the release of estrogen. In
men, this hormone stimulates the production of sperm (Follicle).
In this particular study, the team aimed to investigate the relationship between ethnicity
and IVF outcome in a large population that received treatment over a period of five years
between 2006 and 2011. The IVF outcome between minorities and subpopulation groups such as
South-East Asian, African-Caribbean, and Middle Eastern were compared to white European
groups. For this particular study, all women who participated were undergoing their first cycle of
IVF treatment to try and reduce variability. The study was performed in the UK at the
Nottingham University Research and Treatment Unit in Reproduction. All of the patients
underwent a standard long agonist or antagonist protocol, depending on their ovarian reserve
tests. The difference between these two protocols is the time in which the patient received the
gonadotrophin-releasing hormone. For the long agonist protocol, the gonadotrophin is started in
the midluteal phase of the menstrual cycle while during the antagonist protocol, it is commenced
on day two. The starting doses of gonadotropin were dependent on the woman’s age and ranged
from 150-450 iu. The women were then monitored for follicle development with a serious of
transvaginal ultrasound beginning on the fifth or sixth day of simulation. As soon as the doctors
noticed three follicles measuring more 18mm or more in diameter, oocyte retrieval was
performed 36 hours later. The oocytes are then fertilized in the lab and depending on the number
of embryos that developed, a maximum of two embryos was transferred into the uterus at days 2,
13

3, or 5 after insemination. All of the pregnant women were followed up to record accurately the
final outcome of their pregnancies (Jayaprakasan).
The data was then recorded in a Microsoft Excel spreadsheet and analyzed using various
statistical methods. Their first step was to test for normality to choose the appropriate statistical
test. Continuous data was analyzed by the Student T-test or by the U-test, depending on the data
distribution. The Chi Square test and Fisher were performed to analyze the relationship between
two categorical variables. Out of the 1517 women who began the treatments, 23 did not reach the
egg-retrieval stage, 11 developed an excessive response, 5 had no eggs to be collected, 9 had no
mature eggs, 39 failed fertilization, and 1395 had embryo transfer. Their results on a univariate
logistic regression analysis, was that ethnicity was an independent predictor of live birth rate
with a p-value of less than or equal to .02. On a regression analysis, ethnicity proved to not be a
predictor of successful IVF outcome only when the South-East Asian population was included in
the population with a p-value of .06 (Jayaprakasan).
Based on the experiment, the data indicate that live birth rates, clinical pregnancy rates,
and implantation rates followed by IVF are significantly lower in ethnic groups when compared
to European women. It proves that ethnicity may be a major determinant of live birth following
IVF treatment. When the subgroups were analyzed, success rates were lower in the South-East
Asian, African-Caribbean, and Middle-Eastern groups but not statistically significant possibly
because of the small group sizes. It is important to tell patients realistically, what their
probabilities are of having a positive outcome. Although this research indicated that ethnicity
affects the probabilities of a successful outcome, further research is needed to know the degree of
variation in success caused by different ethnic backgrounds. There may be modifications
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available to the clinical strategies of IVF to ensure equivalent success rates among all ethnic
groups when the relationship between ethnicity and IVF outcomes are thoroughly understood.
Age

JunHao Yan,, et al., conducted a retrospective, observational study of 11,830 IVF-ET
IVF
(in
vitro fertilization embryo transfer) cycles. The women were aggregated into four age groups, 2121
30, 31-35, 36-40,
40, and 40+. Many factors were analyzed in the study, including; the dosage of
Gonadatropin, mean number of oocytes received, 2PN zygote rates, good quality embryo rates,
clinical pregnancy rates, miscarriage rates, and birth defect rates. The following graphic shows
the significant findings:

Figure 1: IVF Outcomes of Different Maternal Age Groups

Source: Yan, JunHao, KeLiang Wu, Rong Tang, LingLing Ding, and Zi
Zi-Jiang
Jiang Chen. "Effect of
Maternal Age on the Outcomes of in Vitro Fertilization and Embryo Transfer (IVF-ET)."
(IVF
Science China Life Sciences,, 55.8 (2012): 694
694-698.
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The findings were interesting in that age does not seem to play a factor in the quality of
day 3 embryos and 2PN zygote rates. However, the tests showed significant findings of lower
pregnancy rates in those of increasing age, as well as miscarriage rate. The miscarriage rates
match those of natural pregnancy though, and thus other factors such as uterine anatomical
defects, environmental factors obesity, endometriosis, etc can be in effect. The study concluded
that age significantly plays a role in IVF success, and pregnancy in general. The authors state
that women 21 through 30 years of age will have the best IVF outcomes of the women of fertile
age (Yan).
A similar study conducted at the Reproductive Medicine Center of the Third Affiliated
Hospital of Guangzhou Medical College by Hong-zi Du, et. al, looked at the effects of patient
age, and number and quality of transferred embryos. The study grouped the infertile women into
three age groups, <30, 31-34, and >=35. The results found that it is desirable to select a single
good-quality embryo for patients <30 and two good-quality embryos for women >30. As women
age, poor-quality embryos should not be transferred at all, and more than two good-quality
embryos may need to be transferred (Du).
Body Mass Index

Obesity is also considered to be a factor influencing the success of IVF treatment. Not
only does the patient’s Body Mass Index (BMI) affect the dosage of gonadotropins, but it can
also have effects on the reproductive tissues and organs, leading to increases in maternal and
neonatal complications (Bellver). A retrospective analysis was performed by D.K. Shah, et al.,
on the effect of BMI on IVF outcomes. The results were presented as odds ratios (OR) and
confidence intervals. Eight hundred ninety-three women were studied with varying BMIs. Those
with Class II and III obesity (BMI of 35.0-39.9 and >=40.0, respectively) had much lower peak
16

estradiol levels (2123 pg/mL vs. 1664 and 1366, p<0.05), fewer oocytes retrieved (15 vs. 11 and
12, p<0.0001), and fewer total embryos (14 vs. 11 and 12, p<0.0001). Women with Class III
obesity also had lower live birth rates (OR=0.4, CI = 0.18-0.88) and a 29% greater incidence of
immature oocytes (CI = 1.11-1.81) compared to subjects with normal BMI (18.5-24.9) (Shah).
Another study that accounts for obesity and BMI includes Zaher O. Merhl et al.’s article
on male adiposity and how it affects clinical pregnancy rates but not the day 3 embryo quality
score. Merhl and company retrospectively studied 344 infertile couples, focusing on several
areas: the number of oocytes retrieved, zygote PN-score, total number of embryos available on
day 3, number of embryos transferred, composite day 3 grade for transferred embryos, composite
day 3 grade per cycle, and CPR. The results found one hundred twenty-one cycles resulted in
clinical pregnancy (35.2%). The normal BMI category was associated with a much higher CPR
(46.7%) than that of the overweight and obese BMI categories (32.0% averaged CPR). There
were no significant differences in any of the other factors analyzed. The study concluded that,
“embryo grading based on conventional morphologic criteria does not explain the poorer clinical
pregnancy outcomes seen in couples with overweight or obese male partners” (Merhl).
Tobacco Smoking

Cigarette smoking is widely believed to be associated with decreased fecundity outcomes
in naturally conceiving populations. The effect of female smoking on pregnancy outcomes in
patients undergoing IVF however is still unclear and over the last few decades, smoking among
women of reproductive age has increased. Lifestyle habits such as smoking may indeed play a
crucial role in the success rates of IVF. Tobacco smoke contains hundreds of substances
including but not limited to nicotine, carbon monoxide, and mutagens. There have been 16
studies all divided into retrospective studies, prospective studies, and meta-analysis that have
17

investigated the effect of smoking on IVF (Kettel). In almost all of these studies, smoking did not
uniformly affect the same endpoints. The studies showed that maternal smoking decreased
fertilization rates, number of oocytes, pregnancy rates, and increased miscarriage rates. In other
studies there was no effect of smoking on fertilization and pregnancy rates. Other studies simply
just did not have the adequate power to assess significant differences in pregnancy outcomes.
The biggest mistake in some of these was not defining the smoking history of each patient with
sufficient details. Smoking was classified when patients first entered the study, but not
throughout the procedure where their habits may have changed. Women who stopped smoking
cigarettes after commencing the treatment were classified as current smokers given that their
habits had changed (Seibel).
The study conducted by Hilary Klonoff-Cohen, Loki Natarajan, Richard Marrs, and Bill
Yee focused on evaluating all biological and reproductive endpoints. It involved both females
and males and also performed multivariate analyses and adjusted for potential confounders and
interaction terms. The quantity, frequency, and duration of smoking was also carefully taken into
account. The study included 221 couples undergoing IVF treatment in Los Angeles, Orange and
San Diego counties. All subjects were between the ages of 20-40 years old and the subjects over
35 years old were analyzed separately because of an increase incidence of miscarriage. The
smoking habits were categorized by the following time periods: lifetime, 1 year, 1 month, 1
week, and one day prior to the procedure. In addition, all of the patients smoking habits were
monitored throughout the entire procedure (Kettel).
When conducting multivariate analyses, the RR for not achieving pregnancy was 2.41
with a p-value of .03 for smoking compared with non-smoking couples. There was a 40%
decrease in the number of oocytes aspirated from smoking couples during the IVF treatment. Of
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the 41 couples who had successful live birth deliveries, 11 had multiple births. The smoking
effects on the multiple births were assessed using a logistic regression. For multiple deliveries,
there was a 9% higher RR for each additional year that the person smoked before being treated
with IVF. The data also concluded that if a woman ever smoked during her lifetime, her risk of
not having a successful pregnancy increased by 9% per year that the individual smoked. In
conclusion, the above study provides compelling evidence that smoking negatively affects the
probabilities of a successful pregnancy outcome (Kettle).
There have been a lot of studies showing how smoking can affect a successful live birth
when undergoing an IVF treatment, but can second hand smoking also affect a successful
outcome? Secondhand tobacco smoke (STS) is a mixture of over 4000 chemicals, where more
than 60 of them are known or suspected carcinogens or reproductive toxins (Lindbohm). In a
previous study, self-reported female STS exposure was associated with decreased implantation
and pregnancy rates among the 225 women tested undergoing IVF (Neal). The increasing use of
assisted reproductive technology, in particular IVF, has helped improve doctor’s abilities to
study contributing factors that lead to infertility and early pregnancy loss. Follicle Fluid also
stated as FF, is the fluid that surrounds the preovulatory oocyte. It is collected during IVF
treatment but very seldom used although it has the potential to serve as a matrix to measure
markers of exposure to STS or other environmental agents. The amount of cotinine levels in FF
are an indicator of a developing oocytes direct exposure to tobacco (Fabro).
The following study was designed to examine the relationship between female STS
exposure and failed implantations using the cotinine dosages in FF in women undergoing IVF.
The study used women who had an IVF treatment from 1994-2003 at one of three Boston clinics.
The total number of participants was 1909 couples with a total of 3270 treatment cycles. The

19

physicians and technicians retained the FF from the participants during egg retrieval for each
cycle. The FF was aspirated from the follicles using a 16 G needle and suction from a Rocket
pump apparatus and then transferred to a petri dish. The fluid, which would normally be
discarded at this point, was placed into a 15 ml tube and centrifuged for 15 minutes. After, it was
transferred to the Brigham and Women’s hospital laboratory for analysis (Benedict, Stacey).
The data analysis was performed using SAS software where cotinine concentrations were
recorded. The study established that the cycles with STS exposed would yield FF cotinine
concentrations of <10 and >1.1 ng/ml and unexposed cycles were < 1.11 ng/ml. The potential
confounding variables were female age, BMI, ethnicity, primary infertility diagnosis, site of
treatment, months spent trying to get pregnant, etc. (Homer). The results showed a significant
increase in the risk of failed implantation among women exposed to STS in comparison to those
unexposed. Based on a 95% CI with a p-value of .004, it was concluded that there is also a
relationship between STS exposure and IVF treatment success. In an analysis among 921 women
who had urine samples available for cotinine measurement, creatinine-adjusted cotinine levels in
urine were associated with a slight decrease in first-cycle implantation rates among non-smoking
women (11.1% in the lowest cotinine quintile versus 8.2% in the highest quintile; P = 0.13
(Meeker).
In conclusion, this study found a significant increase in the risk of implantation failure
among women exposed to STS compared with those who were unexposed based on cotinine
concentrations measured in the FF of the women. They also found a significant decrease in the
odds of achieving a successful live birth among STS-exposed women.
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Breakthroughs and Obstacles

IVF doctors and scientists have been at the top of fertility research and treatment since
the first successful IVF birth in Australia. This procedure is nowhere near perfect and there is
always room for improvement as well as new side effects surfacing. As of now there is not a
standardized procedure to determine the quality of an IVF procedure. There are still many
variables that can affect the number and quality of oocytes and embryos in patients.
Recent research done by Dr. Rinchen Zangmo the Departments of Obstetrics and
Gynecology in New Delhi, India has evaluated the role of dehydroepiandrosterone (DHEA) on
the number and quality of oocytes and embryos in patients who have not been successful with
IVF cycles. To better understand the experiment done by Dr. Zangmo, it is crucial to have an
understanding of what DHEA really is. DHEA is a hormone that is naturally made by the human
body, specifically the adrenal gland and brain (Zangmo). This hormone leads to the production
of androgens and estrogens in both males and females. Although the human body produces
DHEA, scientists have now also found a way to synthetically produce it with chemicals found in
wild yam and soy. It is important to note that the human body cannot produce this hormone by
simply eating wild yam and soy.
For this experiment, a total of 50 patients with a record of poor ovarian response in the
previous IVF cycles participated. The patients were categorized into two different age groups,
where half of them were under 35 and the other half were over 35 years of age. They were
treated with 25 mg of DHEA three times a day for a period of four months. The oocyte and
embryo number and quality were recorded before and after the four months and then analyzed
using a student paired T-test. The results showed an increase of mature oocytes after the 4 month
period of DHEA treatment with patients under 35 having a P<.001 and patients over 35 years of
age yielding a P = 0.002. There were significant increases in the total number of oocytes
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retrieved, fertilization rates, thus increasing the number of embryos available (Zangmo). In
conclusion, DHEA can help improve pregnancy rate in poor responders with history of previous
failed IVF cycles.
Since there are various factors that may contribute to the successful outcome of IVF
treatment, it is important to have a deep understanding of past experiments conducted in these
areas. Furthermore, identifying and understanding the important considerations and analysis that
have been made in past research is crucial. The studies on these topics will help the team have a
thorough understanding of the topics to provide pertinent analysis and assessment to this
research project.
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Design and Methods
Set-Up

The data that was used for this project was purchased by Dr. Steinleitner and provided by
the Society of Reproductive Technologies (SART) and collected over 3 years. The data included
over 36,800 patients and had a description of every single patient’s age, smoking status, BMI,
FSH level, embryo morphology, day of transfer, number of oocytes retrieved, number implanted,
number of beating hearts, and live births. The data was initially organized by percentile clinic
and patient ID, with each patient’s embryo types being grouped together. To be able to analyze
each embryo individually, the data was stacked using Microsoft Excel so that each embryo
morphology was a unique entry. See Appendix A Table 2 for an example of the stacking before
and after process. Embryo morphology encompasses the data of the embryo that includes the day
in which the embryo was transferred, the stage it was in, and many other characteristics
depending on whether it was transferred on day 3 or day 5.
After this filtering step, the number of entries increased from approximately 36,000 to
73,651. Once the embryos were stacked accordingly, the next step in having useful data for our
analysis was to filter out the cases of embryos that would not be of any value to the study. The
only cases that were useful were those in which all embryos were successful or not. For example
if two embryos were transferred and two embryos implanted, then it could be implied that both
embryos were successful and could trace the characteristics for each one. In the cases where the
number of embryos transferred was greater that the number that implanted, it was impossible to
determine which one of those embryos were the ones that implanted. After filtering the data for a
second time, the final number of embryos that were analyzed were approximately 53,000. The
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implantation rate of each embryo was then calculated by dividing the number of implantations by
the number of embryos transferred. Figure 2, shows the steps taken to create
te our useful data.

Figure 2: Data Processing Stages

The next phase in this project was to identify the questions that needed to be answered
and realize what patient factors could potent
potentially affect each other. Figure 3 below is
i a diagram
that shows the relationships that were analyzed between patient factors and implantation rate.

Figure 3
3: Patient Factor and IR Relationships Analyzed

Once the areas of interest were created, the next step in this process was to group all of
the data to make it categorical and analyze it on JMP. Since the age of the patients ranged all the
way from 17 to 52 years of age, grouping the data made for the analysis to be m
much
uch more
manageable. According to a previous study made by Dr. Steinleitner, tthe
he best groups to separate
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age by were, under 36, between 36 and 39, and over 39 years-old. Clinic percentiles were also
split into 3 groups composed of percentiles 1-30, 40-60, and 70-90. After all of the data was
filtered and grouped, Microsoft Access was used to easily maneuver through the large data set.

Patient Factors

To begin the analysis, several questions were brainstormed to be the basis of the study.
The subject matter can be difficult to comprehend initially and these simply stated questions
helped to clarify what was being researched. The first question that was sought to be answered
was, “Does the patient’s age, BMI or smoking preference have a significant effect on
implantation rate?” Before running any statistical test, a few key assumptions had to be met.
Since the data for implantation rate fell in between 0 and 1, the normality assumption could not
be met. In order to normalize the data, a nominal logistic model was used. After reaching
normality and testing for constant variance, the model was applied. From Figure 4, the threefactor model is shown to be significant with a chi-squared value of less than 0.001. The Effect
Likelihood Ratio Tests table shows that smoking and BMI cannot be concluded to contribute
significantly to the model fit. The report shown in this three-factor model supports the
conclusion that age is the only factor that has an effect on embryo implantation rate. It is evident
based on these results that as a patient gets older, the probabilities of implantation decrease.

Figure 4: Nominal Logistic Model for Implantation Rate

25

The graph below (Figure 5) shows the relationship between IR and age of the patient. It also
shows that based on these conclusions the largest quantity of patients who undergo an IVF
treatment are patients over 32 years of age.

Figure 5: IR by Age

Since smoking preference and BMI could not be proven significant, the effects of only
patient’s age on other factors possibly influencing implantation rate were studied. This brought
about the second question, “Does age play a significant role in the patients FSH blood levels?”
FSH is one of the most important hormones involved in the natural menstrual cycle as well as in
pharmacological (drug-induced) stimulation of the ovaries. It is the main hormone involved in
producing mature eggs in the ovaries.
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Figure 6, shows the one way ANOVA that was used to compare the means of the FSH
grouping using thee F distribution. The data below shows that the constant variance assumption
was met.

Figure 6:: One Way ANOVA of Max FSH by Age Group

The one way ANOVA in Figure 7, concludes that the patient’s age was significant with a p-value
p
less than 0.001 in determining the amount of FSH levels in the patient. The connecting letters
report shows that all FSH level groups were significant. As the patients get older, they will yield
higher levels of FSH than younger patients.

Figure 7:: One Way ANOVA with Letters Report of Age Group and FSH
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To build upon these results, the correlation between FSH levels and number of oocytes
produced were studied. In a regression model, it was found that the maximum FSH level in the
patients’ blood was significant (with a pp-value of < 0.0001) in predicting thee number of oocytes
to be retrieved. The best-fit
fit line does not fit this data well (R
(R-Square
Square value of only 0.06), but
does show the overall trend of the data, indicating some inverse proportionality.

Response Number Oocytes Retrieved
Regression Plot

Figure 8:: Scatter Plot of Number of Oocytes versus FSH Levels

Figure 9: Regression Analysis
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Finally, the last question to be answered was, “Does the number of oocytes produced
affect the embryo implantation rate?”
ate?” For this question, the numbers of oocytes retrieved were
grouped into categories as deemed correct by our professional, clinical reference, Dr.
Steinleitner. The categories assigned were, less than 6, between 6 and 35, and greater than 35. As
the dataa shows, the constant variance assumption was met.

Figure 10: Constant Variance Plot

From the one way ANOVA, the pp-value
value for the model was significant at a level greater
than 99%. The connecting letters report shows that each grouping of oocytes retrieved are
significant and the mean implantation rate decreases as the number of oocytes decrease.
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Figure 11:: One way ANOVA with Letters Report of IR and Oocyte Groupings

Embryo Quality

After producing as many conclusions from the given categories of patient factors data as
possible, the focus moved to determining how embryo morphology quality affected implantation
rate across percentiles. Percentiles were grouped by categories (for ease of analysis) 1st -30th
percentile, 40 – 60th, 70 -90th percentile clinics. To select which embryo groupings were most
beneficial to study, a contingency table was created for each morphology type and its unique
implantation rate for each patient factor. Those groupings with the highest implantation rates
were selected for study. For this analysis, only the youngest age grouping (under 36 years of age)
was used, for ease of analysis and because this group has the least repercussions of age’s effect
on implantation rate. See Appendix B Table 3, for the full contingency table. From the
contingency table, the following groups were selected for study: Expanded Blastocyst, Good
Inner Cell Mass (ICM), Good Trop
Trophectoderm;
hectoderm; Hatching Blastocyst, Good ICM, Good
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Trophectoderm; 8-cell, 0 Fragmentation, Perfect Symmetry; 8-cell, 1-10%
10% Fragmentation,
Perfect Symmetry.
The following analysis shows the implantation rate of Day 5 Expanded Blastocysts with
Good Inner Cell Mass
ss and Good Trophectoderm across percentile groupings.

Figure 12
12: Constant Variance of Percentile Groupings
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Figure 13:: ANOVA of IR and Percentile Grouping (Day 5)

Figure 14 : Letters Report of Day 5 Embryo

The model is found to be significant with a pp-value
value of less than 0.0001, showing higher
performing clinics yielding more successful implantation rates. An Expanded Blastocyst in a 7070
90th percentile clinic has an average IR of 0.391 (std. error of 0.00764) while the same embryo
has an average IR of 0.276 (std. error of 0.01394) in a 1st
1st-30th
30th percentile clinic.
An analysis was also conducted for the day 5 hatching Blastocysts with Good Inner Cell
Mass and Good Trophectoderm
m across percentile groupings. Figure 15 shows that constant
variance was met.
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Figure 15
15: Constant Variance of Day 5 Hatching Blast

Figure 16:: ANOVA of Day 5 Hatching Blast with Letters Report
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The model is not found to be significant meaning that when all three percentile means are
compared, the null hypothesis cannot be rejected. When looking at percentile clinics individually
in the connecting letters report from Figure 16, the groupings with 1-30th percentiles and 70-90
70 th
percentiles are significant. A Hatching Blast in a 70-90th
90th percentile clinic has an average IR of
.427 (std. error of 0.0065) while the same eembryo has an average IR of 0.337 (std. error of
0.01245) in a 1st-30th
30th percentile cclinic. A full table on each embryo’s implantation rate
dependent on morphology and percentile gr
grouping can be found in Appendix C. This finding is
consistent with clinical knowledge that higher performing clinics tend to have better technology
that enables them to grow day 5 embryos, while lower performing clinics lack the technology
techn
to
support day 5 embryos.
The Day 3 analysis began with 8-Cell,
Cell, 0 Fragmentation, Perfect Symmetry embryos.
Again, an ANOVA test was conducted to detect significance between percentile groupings.

1
1-30

40-60

70-90

Percentile

Figure 17: Constant Variance of Day 3 Embryo
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Figure 18: ANOVA Analysis of Day 3 Embryo

From the results, the model is significant with a pp-value
value of 0.0087. The three percentile
groupings are not completely independent.

Figure 19: Letters Report of Day 3 Embryo

Some overlap can be found between the mid
mid-level
level percentiles. The higher performing clinic
group has a mean IR of 0.1785 (std. error of 0.00935) and the lower performing clinics a mean
IR of 0.1355 (std. error of 0.01081
0.01081).

35

The next day 3 embryo that was analyzed was an 8 cell, 11-10%
10% fragmentation, perfect
symmetry. The data was tested for constant variance and passed. The ANOVA test in Figure 20
below showed that he model was significant with a pp-value
value less than .001. In this case it shows
that all three percentile groupings are not independent within this particular embryo morphology.

Figure 20: Anova of Day 3 Embryo

The higher performing clinic
ic group for this 8 cell embryo has a mean IR of 0.125 (std. error of
0.00468)) and the lower performing clinics a mean IR of 0.078665 (std. error of 0.01623).
Clinically, the closeness in performance of embryos with day 3 transfers makes sense. All clinics
are able to produce day 3 embryos. In practice, the hi
higher
gher performing clinics will only transfer
embryos on day 3 if the embryo quality of the patient is low and incubating the embryo any
further will most likely not yield a high quality embryo. See Appendix D for an in depth analysis
of each embryo morphologyy analyzed on JMP.
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Cost Analysis
The IVF process is extremely intensive, both financially and socially, therefore direct and
indirect costs must be taken into account.

Direct Costs

Patients want to spend the least amount of money possible for the best possible results. For IVF,
both the upfront price of a procedure, and the number of treatments need to be considered. A
high-ranked
ranked clinic may charge $10,000 per treatment while a lower
lower-ranked
ranked clinic may charge
$7,000 per treatment. Even though the upfront costs of the lower percentile clinic is cheaper, in
the end, because the success rate is lower in the cheaper clinic, the patient may need several
rounds of IVF accumulating two or three times the amount of the upfront costs. The following
table illustrates
tes this simple model:

Table 2: Cost Comparison

A high-ranking
ranking percentile clinic can charge more for their process, because of their higher IR and
success rate. These treatments are very costly ranging from $16,000 - $800,000, and often represent a
significant economic burden for families. Therefore, making small improvements to their process

can increase benefits for the clinic and patient, in increased revenue and less trials, respectively.
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Indirect Costs

For women, the pregnancy process is extremely emotional. Hoping for a positive result
can be draining, and receiving a negative result, simply earth-shattering. The stress of an
unfulfilled wish for a child has been associated with emotional symptoms such as anger,
depression, anxiety, and feeling of worthlessness. Some patients have rated the stress of
undergoing an IVF cycle as more stressful than or just as stressful as another major life event
such as the death of a family member, separation, or divorce. Physically woman are exposed
most of the time to various rigorous rounds of medications and injections. Patients have said it is
more stressful and uncomfortable to undergo an IVF cycle than a normal menstrual cycle.
Despite the relatively low chance of achieving pregnancy in one IVF cycle, many women have
unrealistic expectations about the treatment success. Many women report a lack of control during
the process and feel like they have little choice but to succumb to the invasive investigations. As
a result of this, feelings of depersonalization can occur.

Undergoing infertility treatments can also have an impact on a patient’s social life. Social
activities are often put on hold because many women are not able or willing to share their
experiences. Furthermore the frequent hospital visits can result in missing a lot of work days. It
can also put a strain on relationships since partners cope with these situations differently.
Overall, IVF treatments put a lot of stress on the patients and their families both psychologically
and financially. Any improvements in the success rate of IVF cycles would greatly benefit
patients and clinics.

38

Results and Discussions
In summary, age is significant with regards to implantation rate and FSH level. FSH
level played an important role in the number of oocytes retrieved, which in turn plays a large role
in determining Implantation success. Also, the older the patient becomes, the higher the
maximum FSH blood level will be which in turn is significant in making the implantation rate
lower. When analyzing whether smoking and BMI were significant regarding implantation, the
null hypothesis could not be rejected. Lastly, Embryo Morphology was significant across
percentile groups, especially within day 5. This means that the process used to grow embryos is
significant in determining an implantation rate.

As stated in the cost analysis section, increasing the implantation rates of the lower
performing clinics could save patients a lot of money and potentially reduce the amount of cycles
a woman undergoes. Each cycle has proven to be mentally and physically straining for each
patient. They can be a negative impact on relationships and even cost them their jobs.
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Future Directions
The amount of information included in this dataset is enormous. There are many areas
that can be expanded upon. Several of these areas, such as differences between percentile groups
and across embryo morphology are being researched for a Master’s thesis. The results of the
mentioned thesis are expected to be a breakthrough in IVF. By studying differences between
percentile groups and embryo morphology, a standardized grading method/scale are hoped to be
produced, along with conclusions about the different processes clinics are using.

Also, using this report as a baseline, expanding implantation rate to live birth rate success
would be an interesting step. This could reveal more effects that the patient has on the successful
completion of growing the fetus. Perhaps then, a significance can be seen in BMI and smoking
preference of the patient.
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Appendix A
Before
Percentile
Group

Patient ID

Age

BMI

Embryo
Morphology
1

Embryo
Morphology
2

70

11111111

34

24.3

Early Blast,
Good

Hatching
Blast, Good

50

1232123

37

25.7

8-cell, 0%
Frag

8-cell, 1-10%
Frag

Percentile

Patient ID

Age

BMI

Embryo
Morphology

MOVED

70

11111111

34

24.3

Early Blast,
Good

70

11111111

34

24.3

Hatching
Blast, Good

50

1232123

37

25.7

8-cell, 0%
Frag

50

1232123

37

25.7

8-cell, 1-10%
Frag

After

Table 3: Stacking Process
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Appendix B

Table 4: Embryo morphology Contingency Tables

49

Appendix C

Table 5:: Percentile Grouping Contingency Table by Embryo Morphology
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Appendix D
One way Analysis of IR By Percentile – Day 5 Exp. Blast – Good

40-60

1-30

70-90

Percentile

Oneway Anova
Summary of Fit
Rsquare
Adj Rsquare
Root Mean Square Error
Mean of Response
Observations (or Sum Wgts)
Analysis of Variance
Source
Percentile
Error
C. Total
Means for Oneway Anova
Level
Number
1
607
2
1083
3
2022

0.017394
0.016864
0.343392
0.350777
3712

DF Sum of Squares
2
7.74195
3709
437.35775
3711
445.09970

Mean
0.276085
0.318252
0.390620

Std Error
0.01394
0.01043
0.00764

Mean Square
3.87098
0.11792

Lower 95%
0.24876
0.29779
0.37565

F Ratio
32.8277

Prob > F
<.0001*

Upper 95%
0.30341
0.33871
0.40559

Means Comparisons
Comparisons for each pair using Student's t
Confidence Quantile
t
Alpha
1.96060
0.05
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LSD Threshold Matrix
Abs(Dif)-LSD
3
2
1

3
-0.02117
0.04702
0.08338

2
0.04702
-0.02893
0.00803

1
0.08338
0.00803
-0.03865

Positive values show pairs of means that are significantly different.
Connecting Letters Report
Level
3
2
1

Mean
0.39061985
0.31825177
0.27608457

A
B
C

Levels not connected by same letter are significantly different.
Ordered Differences Report
Level
- Level
Difference
3
1
0.1145353
3
2

2
1

0.0723681
0.0421672

Std Err Dif
0.0158928

Lower CL
0.0833758

Upper CL
0.1456948

p-Value
<.0001*

0.0129305
0.0174110

0.0470165
0.0080310

0.0977197
0.0763034

<.0001*
0.0155*

Oneway Analysis of IR By Percentile Day 5 – Hatching- G-G

40-60

1-30

70-90

Percentile
Oneway Anova
Summary of Fit
Rsquare
Adj Rsquare
Root Mean Square Error
Mean of Response

0.009245
0.007108
0.37822
0.37043

1-30

70-90

Percentile

40-60
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Observations (or Sum Wgts)

930

Analysis of Variance
Source
DF Sum of Squares
Percentile
2
1.23743
Error
927
132.60773
C. Total
929
133.84516
Means for Oneway Anova
Level
Number
1
425
2
292
3
213

Mean
0.404706
0.363014
0.312207

Mean Square
0.618714
0.143050

Std Error
0.01835
0.02213
0.02592

F Ratio
4.3251

Lower 95%
0.36870
0.31958
0.26135

Prob > F
0.0135*

Upper 95%
0.44071
0.40645
0.36307

Std Error uses a pooled estimate of error variance
Means and Std Deviations
Level
Number
1
2
3

425
292
213

Mean

Std Dev

0.404706
0.363014
0.312207

0.370965
0.392238
0.372955

Std Err
Mean
0.01799
0.02295
0.02555

Lower 95%

Upper 95%

0.36934
0.31784
0.26183

0.44008
0.40819
0.36258

Means Comparisons
Comparisons for all pairs using Tukey-Kramer HSD
Confidence Quantile
q*
Alpha
2.34748
0.05
LSD Threshold Matrix
Abs(Dif)-HSD
1
2
3

1
-0.06091
-0.02579
0.01796

2
-0.02579
-0.07348
-0.02920

3
0.01796
-0.02920
-0.08603

Positive values show pairs of means that are significantly different.
Connecting Letters Report
Level
1
2
3

A
A

Mean
0.40470588
0.36301370
0.31220657

B
B

Levels not connected by same letter are significantly different.
Ordered Differences Report
Level
- Level
Difference
1
3
0.0924993
2
1

3
2

0.0508071
0.0416922

Std Err Dif
0.0317520

Lower CL
0.017962

Upper CL
0.1670364

p-Value
0.0102*

0.0340807
0.0287487

-0.029197
-0.025795

0.1308109
0.1091791

0.2958
0.3157
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Oneway Analysis of IR By Percentile Day 3 – 8 cell – 0 - Perf

40-60

1-30

70-90

Percentile

Oneway Anova
Summary of Fit
Rsquare
Adj Rsquare
Root Mean Square Error
Mean of Response
Observations (or Sum Wgts)

0.006125
0.004838
0.242918
0.15778
1548

Analysis of Variance
Source
DF Sum of Squares
Percentile
2
0.561819
Error
1545
91.169458
C. Total
1547
91.731278
Means for Oneway Anova
Level
Number
1
505
2
368
3
675

Mean
0.135479
0.150344
0.178519

Mean Square
0.280910
0.059009

Std Error
0.01081
0.01266
0.00935

Lower 95%
0.11428
0.12551
0.16018

F Ratio
4.7604

Prob > F
0.0087*

Upper 95%
0.15668
0.17518
0.19686

Std Error uses a pooled estimate of error variance
Means Comparisons
Comparisons for all pairs using Tukey-Kramer HSD
Confidence Quantile
q*
Alpha
2.34597
0.05
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LSD Threshold Matrix
Abs(Dif)-HSD
3
2
1

3
-0.03102
-0.00875
0.00951

2
-0.00875
-0.04201
-0.02419

1
0.00951
-0.02419
-0.03586

Positive values show pairs of means that are significantly different.
Connecting Letters Report
Level
3
2
1

A
A

Mean
0.17851852
0.15034420
0.13547855

B
B

Levels not connected by same letter are significantly different.
Ordered Differences Report
Level
- Level
Difference
3
1
0.0430400
3
2

2
1

0.0281743
0.0148657

Std Err Dif
0.0142924

Lower CL
0.009511

Upper CL
0.0765694

p-Value
0.0074*

0.0157408
0.0166494

-0.008753
-0.024193

0.0651017
0.0539245

0.1733
0.6449

Oneway Analysis of IR By Percentile – 8 Cell – 1-10%- Perfect

Oneway Anova
Summary of Fit
Rsquare
Adj Rsquare
Root Mean Square Error
Mean of Response
Observations (or Sum Wgts)

0.024008
0.022236
0.24011
0.140121
1105

Analysis of Variance
Source
DF Sum of Squares
Percentile
2
1.562800
Error
1102
63.533517
C. Total
1104
65.096317

40-60

1-30

Means for Oneway Anova
Level
Number
1-30
305
40-60
503
70-90
297

Mean Square
0.781400
0.057653

Mean
0.090164
0.178595
0.126263

Percentile
Std Error
0.01375
0.01071
0.01393

F Ratio
13.5535

Prob > F
<.0001*

70-90

Lower 95%
0.06319
0.15759
0.09893

Upper 95%
0.11714
0.19960
0.15360

Std Error uses a pooled estimate of error variance
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Means Comparisons
Comparisons for all pairs using Tukey-Kramer HSD
Confidence Quantile
q*
Alpha
2.34688
0.05
LSD Threshold Matrix
Abs(Dif)-HSD
2
3
1

2
-0.03553
0.01110
0.04754

3
0.01110
-0.04624
-0.00984

1
0.04754
-0.00984
-0.04563

Positive values show pairs of means that are significantly different.
Connecting Letters Report
Level
70-90
40-60
1-30

Mean
0.17859510
0.12626263
0.09016393

A
B
B

Levels not connected by same letter are significantly different.
Ordered Differences Report
Level
- Level
Difference
2
1
0.0884312
2
3
0.0523325
3

1

0.0360987

Std Err Dif
0.0174254
0.0175709

Lower CL
0.047536
0.011096

Upper CL
0.1293264
0.0935692

p-Value
<.0001*
0.0083*

0.0195741

-0.009839

0.0820366

0.1558
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